SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-15-011199
Filing Date
2015-05-28
Accepted
2015-05-28 12:02:30
Documents
23
Period of Report
2015-05-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdli20150527_8k.htm 8-K 28564
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 13401
3 a21.jpg GRAPHIC 114671
4 a20.jpg GRAPHIC 141051
5 a19.jpg GRAPHIC 73848
6 a18.jpg GRAPHIC 137904
7 a17.jpg GRAPHIC 71563
8 a16.jpg GRAPHIC 141009
9 a15.jpg GRAPHIC 73363
10 a14.jpg GRAPHIC 178106
11 a13.jpg GRAPHIC 195467
12 a12.jpg GRAPHIC 128027
13 a11.jpg GRAPHIC 189206
14 a10.jpg GRAPHIC 163939
15 a9.jpg GRAPHIC 157758
16 a8.jpg GRAPHIC 168077
17 a7.jpg GRAPHIC 78392
18 a6.jpg GRAPHIC 95152
19 a5.jpg GRAPHIC 78585
20 a4.jpg GRAPHIC 78813
21 a3.jpg GRAPHIC 98485
22 a2.jpg GRAPHIC 221619
23 a1.jpg GRAPHIC 87399
  Complete submission text file 0001437749-15-011199.txt   3727453
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 15894542
SIC: 2836 Biological Products, (No Diagnostic Substances)